You are here

ESC

ESC 2021: Bayer's Kerendia touts outcomes data as it looks to complement J&J, AZ drugs

Fierce Pharma

Sat, 08/28/21 - 09:02 pm

clinical trials

ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study

Fierce Pharma

Mon, 08/31/20 - 10:49 am

Bristol-Myers Squibb

site-specific bleeding

ESC: Merck's Steglatro shows limited promise with heart failure hospitalization data

Fierce Pharma

Mon, 08/31/20 - 10:44 am

ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one

Fierce Pharma

Mon, 08/31/20 - 10:20 am

ESC 2020 – Farxiga impresses in chronic kidney disease

EP Vantage

Mon, 08/31/20 - 10:14 am

chronic kidney disease

clinical trials

ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit

EP Vantage

Mon, 08/31/20 - 10:13 am

Boehringer Ingelheim

ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha

Fierce Pharma

Sun, 08/30/20 - 11:25 pm

ESC: AstraZeneca's SGLT2 med Farxiga flips script on competitors with 26% CV risk cut

Fierce Pharma

Wed, 09/4/19 - 11:48 am

ESC 2019 – Amarin hopes for guideline boost despite regulatory delay

EP Vantage

Tue, 09/3/19 - 10:54 am

European Society of Cardiology

MedCo's PCSK9 challenger steals the show at ESC with winning data

Fierce Pharma

Mon, 09/2/19 - 12:27 pm

Medicines Company

PCSK9 inhibitors

European Society of Cardiology

ESC: Novartis looks for the bright side in flopped Entresto heart failure study

Fierce Pharma

Mon, 09/2/19 - 12:19 pm

clinical trials

European Society of Cardiology

ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe

Fierce Pharma

Mon, 09/2/19 - 12:17 pm

Bristol-Myers Squibb

European Society of Cardiology

ESC 2018 preview – A possible boost for Abbott, and balloons go up against stents

EP Vantage

Sun, 08/19/18 - 04:26 pm